Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes

H.S.P. Garritsen; C. Constantin; F. Griesinger; A. Kolkmeyer; R.M.P. Doornbos; B.G. de Grooth; Jan Greve; B. Wormann; W. Hiddemann

Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes

H.S.P. Garritsen, C. Constantin, F. Griesinger, A. Kolkmeyer, R.M.P. Doornbos, B.G. de Grooth, Jan Greve, B. Wormann, W. Hiddemann

Research output: Other contribution › Other research output

Original language	Undefined
Publication status	Published - 1 Jun 1996

Keywords

METIS-131500

Cite this

@misc{0a142845f297440f95b234bd03ffee8d,

title = "Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes",

keywords = "METIS-131500",

author = "H.S.P. Garritsen and C. Constantin and F. Griesinger and A. Kolkmeyer and R.M.P. Doornbos and {de Grooth}, B.G. and Jan Greve and B. Wormann and W. Hiddemann",

year = "1996",

month = jun,

day = "1",

language = "Undefined",

type = "Other",

}

TY - GEN

T1 - Interleukin-2 Postremission Therapy in Acute Myeloid Leukemia (AML): In Vitro and In Vivo Effects of a Five Day Continuous Infusion of IL-2 on Phenotype and Function of Peripheral Lymphocytes

AU - Garritsen, H.S.P.

AU - Constantin, C.

AU - Griesinger, F.

AU - Kolkmeyer, A.

AU - Doornbos, R.M.P.

AU - de Grooth, B.G.

AU - Greve, Jan

AU - Wormann, B.

AU - Hiddemann, W.

PY - 1996/6/1

Y1 - 1996/6/1

KW - METIS-131500

M3 - Other contribution

ER -